Characterisation of Syncytiotrophoblast Vesicles in Normal Pregnancy and Pre-Eclampsia: Expression of Flt-1 and Endoglin

Tannetta, Dionne S.; Dragovic, Rebecca A.; Gardiner, Chris; Redman, Christopher W.; Sargent, Ian L.
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Background: The placental syncytiotrophoblast releases micro and nanovesicles (STBM), into the maternal circulation in normal pregnancy and in increased amounts in pre-eclampsia (PE), which have proinflammatory and antiangiogenic activity and are implicated in PE pathophysiology. Better characterisation of STBM is essential to understand their role in PE. Methods and Results: STBM prepared by placental lobe dual perfusion (pSTBM) and mechanical disruption (mSTBM) were analysed by four colour flow cytometry (4CFC), nanoparticle tracking analysis (NTA) and Western blotting to determine vesicle size, purity and Flt-1 and endoglin (Eng) expression. Biological activity of STBM associated Flt-1 and endoglin was assessed by the ability of VEGF, PlGF and TGFβ to bind to mSTBM and inhibit mSTBM induced endothelial monolayer disruption. STBM content was consistently high (∼87–95%) across the different preparations. However, surface antigen intensities differed, with significantly lower placental alkaline phosphatase (P<0.05) and Eng (P<0.05) expression on mSTBM, and Flt-1 (P<0.05) expression on pSTBM. For PE placenta derived preparations, pSTBM contained lower Eng positive STBM (P<0.05) and mSTBM Eng expression was increased (P<0.05). Western blotting revealed increased Flt-1/sFlt-1 (P<0.02) and decreased placental alkaline phosphatase (P = 0.0002) content of PE placenta pSTBM. Using NTA, perfused PE placentas released significantly larger MV (P<0.001). Finally, VEGF, PlGF and TGFβ bound to mSTBM at physiologically relevant concentrations and inhibited mSTBM induced endothelial disruption (P<0.05-P<0.001). Conclusions: This study has found differences in physical and antigenic characteristics of normal and PE placenta STBM preparations produced by placental perfusion or mechanical disruption. We have also demonstrated that large quantities of biologically active STBM associated endoglin and Flt-1/sFlt-1 could contribute to the increased circulating levels measured in PE patients and add to the perturbation of the maternal vascular endothelium, normally attributed to non-membrane bound sFlt-1 and sEndoglin.


Related Articles

  • Placental Expression of miR-517a/b and miR-517c Contributes to Trophoblast Dysfunction and Preeclampsia. Anton, Lauren; Olarerin-George, Anthony O.; Hogenesch, John B.; Elovitz, Michal A. // PLoS ONE;Mar2015, Vol. 10 Issue 3, p1 

    Preeclampsia is a pregnancy specific hypertensive disease that confers significant maternal and fetal risks. While the exact pathophysiology of preeclampsia is unknown, it is widely accepted that placental dysfunction is mechanistically involved. Recent studies reported aberrant expression of...

  • Evaluation of STOX1 as a preeclampsia candidate gene in a population-wide sample. Kivinen, Katja; Peterson, Hanna; Hiltunen, Leena; Laivuori, Hannele; Heino, Sanna; Tiala, Inkeri; Knuutila, Sakari; Rasi, Vesa; Kere, Juha // European Journal of Human Genetics;Apr2007, Vol. 15 Issue 4, p494 

    Preeclampsia is a common, pregnancy-specific vascular disorder characterised by hypertension and proteinuria. A recent report suggested association of the STOX1 gene on chromosome 10q22.1 with preeclampsia in the Dutch population. Here, we present a comprehensive assessment of STOX1 as a...

  • Pre-eclampsia: pathophysiology and its management. Morley, Anne // British Journal of Midwifery;Jan2004, Vol. 12 Issue 1, p30 

    Describes the pathophysiology and management of pre-eclampsia in pregnant women. Activation of endothelial cells; Loss of epithelial cell integrity; Increase in vascular permeability; Impact of blood pressure on management; Effect of pre-eclampsia on hematological system; Assessment of fetal...

  • Variation in endoglin pathway genes is associated with preeclampsia: a case-control candidate gene association study. Bell, Mandy J.; Roberts, James M.; Founds, Sandra A.; Jeyabalan, Arun; Terhorst, Lauren; Conley, Yvette P. // BMC Pregnancy & Childbirth;2013, Vol. 13 Issue 1, p1 

    Background: Preeclampsia is a hypertensive, multi-system pregnancy disorder whose pathophysiology remains unclear. Elevations in circulating soluble endoglin (sENG) and placental/blood ENG mRNA expression antedate the clinical onset of preeclampsia. This study investigated if endoglin (ENG)...

  • Hypertensive Disorders of Pregnancy: A Review. Prasad, Rajeev; Fischer, Michael J. // Kidney;Sep/Oct2005, Vol. 14 Issue 5, p205 

    Presents an overview of hypertensive disorders occurring during pregnancy and explores the recent developments in understanding preeclampsia. Categories of hypertension disorders during pregnancy; Pathophysiology of preeclampsia; Characteristics of preeclamptic women; Link between preeclampsia...

  • NHBPEP Report on High Blood Pressure in Pregnancy: A Summary for Family Physicians. Zamorski, Mark A.; Green, Lee A. // American Family Physician;7/15/2001, Vol. 64 Issue 2, p263 

    Provides information on the report issued by the National High Blood Pressure Education Program on high blood pressure in pregnancy. Hypertensive disorders of pregnancy; Pathophysiology of preeclampsia; Treatment for hypertension in pregnancy.

  • Screening for preeclampsia pathogenesis related genes. Y.-H. YAN; P. YI; Y.-R. ZHENG; L.-L. YU; J. HAN; X.-M. HAN; L. LI // European Review for Medical & Pharmacological Sciences;Nov2013, Vol. 17 Issue 22, p3083 

    OBJECTIVES: Preeclampsia is a complication of pregnancy that severely threatens the health of the mother and infant, yet the mechanism of pathogenesis remains unclear. In this article, gene array technology was applied to identify the genes related to the pathogenesis of preeclampsia, and to...

  • CHAPTER 47: HYPERTENSION, ELEVATED LIVER ENZYMES, AND LOW PLATELETS (HELLP). CETIN, ALI // Advanced Therapy in Hypertension & Vascular Disease;2006, p416 

    Chapter 47 of the book "Advanced Therapy in Hypertension & Vascular Disease" is presented. It discusses the Hypertension, Elevated Liver Enzymes and Low Platelets (HELLP) syndrome, a variant presentation of severe preeclampsia. It was observed that two-thirds of HELLP syndrome cases are...

  • Lipopolysaccharide-Induced Lung Injury Is Independent of Serum Vitamin D Concentration. Klaff, Lindy S.; Gill, Sean E.; Wisse, Brent E.; Mittelsteadt, Kristen; Matute-Bello, Gustavo; Chen, Peter; Altemeier, William A. // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Vitamin D deficiency is increasing in incidence around the world. Vitamin D, a fat-soluble vitamin, has documented effects on the innate and adaptive immune system, including macrophage and T regulatory (Treg) cell function. Since Treg cells are important in acute lung injury resolution, we...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics